Compare Illumina, Inc. (ILMN) vs S&P500 ETF (SPY) Price & Performance

Illumina, Inc.Trade

S&P500 ETFTrade

Price performance (Past 24H)

Key statistics

Illumina, Inc. vs S&P500 ETF — how do they compare? Illumina, Inc. trades at $180.13 (market cap $27.94B), while S&P500 ETF trades at $745.5. Which is the better fit depends on your goals.

	ILMN	SPY
Market Cap	$27.94B	—
Sector	Health	—
52-Week High	$194.33	$759.55
52-Week Low	$91.00	$621.75
Enterprise Value	$29.33B	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Illumina, Inc.

No Aura AI signal available yet.

S&P500 ETF

SPY trades at $742.21, down 0.13% with a bearish technical outlook. The S&P 500 index faces pressure, declining 1.6% last week and trading below its 50-day moving average. Recent news highlights concerns about market concentration in tech stocks and elevated valuations, though some analysts see potential for continued gains. A dividend of $1.90 is scheduled for July 2026.

The ETF's outlook is mixed amid technical weakness and valuation debates. While earnings season shows strength, market concentration and fee comparisons with sister funds present risks. The bearish technical signal suggests near-term caution, though long-term index exposure remains a core portfolio strategy for many investors.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ILMN

Cancer biomarkers market to hit $54.48B by 2032, driven by tech advances and Asia-Pacific growthResearchandmarkets.Com · 4 days agoBullish New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral Illumina's Billion Cell Atlas adds Formation Bio to boost AI-driven drug discovery with massive genomic data.PRNewsWire · 4 days agoBullish View details →

SPY

John Hancock Financial Opportunities Fund offers 6.5% growing dividend, beating S&P 500 and financial ETFs.Forbes · 4 hours agoBullish XLK ETF hides high concentration risk in top tech stocks despite low fees.24/7 Wall Street · 15 hours agoNeutral Global markets mixed in 2026, Japan's Nikkei leads with 27.4% gain, India's Sensex lags down 8.8%.ETF Trends · 17 hours agoNeutral View details →

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About S&P500 ETF

The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.